erythroplakia
erythroplakia
Explore linked clinical trials. Standard reference: MONDO:00230893 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia | Erythroplasia, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, erythroplakia, leukoplakia, mouth disorder, neoplasm, oral mucosa leukoplakia, precancerous condition | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05237960 | |
| Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer | Bone Marrow Failure Disorders, Chemically-Induced Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Erythroplasia, Fanconi anemia, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Lichenoid Eruptions, Mouth Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Stomatognathic Diseases, anemia, aplastic anemia, bone marrow disorder, erythroplakia, hematologic disorder, hereditary disease, hereditary mucosal leukokeratosis, hereditary skin disorder, inherited aplastic anemia, lichen planus, metabolic disease, mouth disorder, neoplasm, nicotine dependence, precancerous condition, psychiatric disorder, skin disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-09-14 | NCT00542373 | |
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | Erythroplasia, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, erythroplakia, hyperplasia, leukoplakia, mouth disorder, neoplasm, oral cavity carcinoma, oral mucosa leukoplakia, precancerous condition | Active, not recruiting | Phase 2 | 2026-06-26 | NCT02581137 |